Cellular renewal kinetics of malignant non-Hodgkin's lymphomas.

Cellular renewal kinetics of malignant non-Hodgkin's lymphomas. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Cellular renewal kinetics of malignant non-Hodgkin's lymphomas. Abstract Text:

K Bremer,

Although the DNA synthesis times of the dividing NHL cell types were found to be within the normal range (7--12 h), the generation times of these neoplastic lymphocytes seem to be prolonged. However, even with a normal percentage of proliferating lymphoma cells (=growth fraction), the total number of mitotically active neoplastic lymphocytes is considerably increased in each NHL due to extensive enlargement of the total cellularity of each patient's lymphatic system. Therefore, in each NHL patient, the total cellularity of each patients' lymphatic system. Therefore, in each NHL patient, the total number of newly produced lymphoma cells is significantly increased. According to the Kiel classification of the NHL, the NHL of low-grade malignancy are considered to be characterized by the proliferative constellation of an enhanced cell production associated with reduced or normal cell death rates, whereas in the NHL of high-grade malignancy, increased cell death rates seem to be overcompensated by even higher cell renewal rates. These differences in the cellular proliferation kinetics of the NHL are supposed to be of higher prognostic and clinical significance than their B- or T-cell properties.

Cellular renewal kinetics of malignant non-Hodgkin's lymphomas. Publishing Authors By Initials

K Bremer,

For similar diagnosis: prognosis research abstracts see: diagnosis: prognosis research

PUBMED ID PMID:

MEDLINE DATE:

Cellular renewal kinetics of malignant non-Hodgkin's lymphomas. Journal Published:

PUBLICATION TYPE: Review

Journal: Recent results in cancer research. Fortschritte de

VOLUME: 65

Page Numbers: 5-11

Journal Abbreviation: Recent Results Cancer Res.

ISSN: 0080-0015

DAY: 13

MONTH: 02

YEAR: 1978

Cellular renewal kinetics of malignant non-Hodgkin's lymphomas. Information

Number of References: 42

LANGUAGE: eng

NlmUniqueID: 44671

Cellular renewal kinetics of malignant non-Hodgkin's lymphomas. Keywords Mesh Terms:

KEYWORDS: Prognosis

MESH TERMS: therapy

Chemical & Substance for Abstract: Cellular renewal kinetics of malignant non-Hodgkin's lymphomas. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Cellular renewal kinetics of malignant non-Hodgkin's lymphomas.

AFFILIATION:

Country: GERMANY, WEST

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Recent Results Cancer Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Cellular renewal kinetics of malignant non-Hodgkin's lymphomas Related Publications

• BOARD-INVITED REVIEW: Use of distillers by-products in the beef cattle feeding industry.
• Cellular renewal kinetics of malignant non-Hodgkin's lymphomas.
• Computerized detection and measurement of drusen in age-related macular degeneration.
• Crystal structure of the ligand-binding protein EhuB from Sinorhizobium meliloti reveals substrate recognition of the compatible solutes ectoine and hydroxyectoine.
• Differentiation of angiogenic burden in human cancer xenografts using a perfusion-type optical contrast agent (SIDAG).
• Embryotoxicity hazard assessment of methylmercury and chromium using embryonic stem cells.
• Estimating divergence times in large phylogenetic trees.
• Evolution and trends in the Psychotrieae alliance (Rubiaceae)-A rarely reported evolutionary change of many-seeded carpels from one-seeded carpels.
• First steps in establishing a developmental toxicity test method based on human embryonic stem cells.
• Gondwanan evolution of the grass alliance of families (Poales).
• In vivo optical imaging of CD13/APN-expression in tumor xenografts.
• In vivo selection and characterization of internal deletions in the lamB::lacZ gene fusion.
• Osmotically induced synthesis of the compatible solute hydroxyectoine is mediated by an evolutionarily conserved ectoine hydroxylase.
• Pain management during uterine artery embolization for symptomatic uterine fibroids.
• Physician recruiting: no small challenge.
• R2 and R2* mapping for sensing cell-bound superparamagnetic nanoparticles: in vitro and murine in vivo testing.
• Rare and enigmatic genera (Dunnia, Schizocolea, Colletoecema), sisters to species-rich clades: Phylogeny and aspects of conservation biology in the coffee family.
• Recovery of spores from thermophilic dairy bacilli and effects of their surface characteristics on attachment to different surfaces.
• Responses of Bacillus subtilis to hypotonic challenges: physiological contributions of mechanosensitive channels to cellular survival.
• Status of plasma and erythrocyte fatty acids and vitamin A and E in young children with cystic fibrosis.
• Synthesis and evaluation of a novel fluorescent photoprobe for imaging matrix metalloproteinases.
• The possible impact of human embryonic stem cells on safety pharmacological and toxicological assessments in drug discovery and drug development.
• The state hospital, Oshakati, Ovamboland.
• Tissue binding of hydrocortisone.
• [Extradural spinal anesthesia according to Buchholz and Lesse in obstetrics.]
• [Historical data on vitamin deficiencies.]
• [Modern methods of labor analgesia.]
• [Not Available.]
• [Not Available.]
• [Results of experiments with the antihypotonic drug Normotin-R (rapid) and Normotin-P (protracted in ambulatory practice]